Authors: BETTENCOURT MC BAUER JJ SESTERHENN IA CONNELLY RR MOUL JW

Citation: Mc. Bettencourt et al., CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE-CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY, The Journal of urology, 160(2), 1998, pp. 459-465

Authors: BETTENCOURT MC MORRIS ER SPEVAK M COSTABILE R

Citation: Mc. Bettencourt et al., THE EFFECT OF HUMAN CHORIONIC-GONADOTROPIN ON METHOTREXATE CONCENTRATION IN THE RAT TESTES, The Journal of urology, 158(4), 1997, pp. 1581-1584

Authors: BAUER JJ CONNELLY RR SESTERHENN IA BETTENCOURT MC MCLEOD DG SRIVASTAVA S MOUL JW

Citation: Jj. Bauer et al., BIOSTATISTICAL MODELING USING TRADITIONAL VARIABLES AND GENETIC BIOMARKERS FOR PREDICTING THE RISK OF PROSTATE CARCINOMA RECURRENCE AFTER RADICAL PROSTATECTOMY, Cancer, 79(5), 1997, pp. 952-962

Authors: MOUL JW BETTENCOURT MC SESTERHENN IA MOSTOFI FK MCLEOD DG SRIVASTAVA S BAUER JJ

Citation: Jw. Moul et al., PROTEIN EXPRESSION OF P53, BCL-2, AND KI-67 (MIB-1) AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH SURGICALLY TREATED, CLINICALLY LOCALIZED PROSTATE-CANCER, Surgery, 120(2), 1996, pp. 159-167

Authors: BETTENCOURT MC BAUER JJ SESTERHENN IA MOSTOFI FK MCLEOD DG MOUL JW

Citation: Mc. Bettencourt et al., KI-67 EXPRESSION IS A PROGNOSTIC MARKER OF PROSTATE-CANCER RECURRENCEAFTER RADICAL PROSTATECTOMY, The Journal of urology, 156(3), 1996, pp. 1064-1068